Natco Pharma

News from other websites on Natco Pharma

Roche gives up on India patent for breast cancer drug

Aug 16, 2013 at 18:00 | Source: VC Circle

Last year, India issued the first ever compulsory licence to domestic drugmaker Natco Pharma on a kidney and liver cancer drug, Nexavar, patented by Germany's Bayer. Roche Holding AG has decided not to pursue a patent application for its brea...

Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India

Aug 16, 2013 at 15:07 | Source: Economic Times

MUMBAI: Swiss drug major Roche has decided not to pursue its patent for anti-cancer drug Herceptin, the patent which had come up for extension till 2019, paving the way for generic drug makers to manufacture this drug. Trastuzumab, sold under the bra...

Natco Pharma Q1 net profit up 28% at Rs 22 cr

Aug 14, 2013 at 19:32 | Source: The Hindu BusinessLine

Natco Pharma’s consolidated net profit increased 28 per cent at Rs 22 crore in the first quarter ended June 30 compared to Rs 17 crore in the same period last year. The revenue of the Hyderabad-based company grew by 21 per cent at Rs 182 crore...

All's not well with pharma

Aug 11, 2013 at 00:12 | Source: The Hindu BusinessLine

When much of India Inc was grappling with the slowdown, pharma companies bucked the trend by sustaining healthy growth. The profits of pharma majors constituting the BSE Healthcare Index grew over 27 per cent in the last three years, compared with a...

Sensex sheds 155 points ahead of RBI policy; Jet Airways up 4%

Jul 29, 2013 at 19:07 | Source: DomainB

The market fell for the fourth consecutive session Monday with the Sensex shedding 155 points ahead of RBI's first quarter review of monetary policy on July 30. The BSE Sensex closed at 19593.28 while the NSE Nifty fell 54.55 points or 0.93 percent ...

Natco Pharma gets favourable ruling for generic Copaxone in US

Jul 28, 2013 at 12:37 | Source: Economic Times

NEW DELHI: Drug firm Natco Pharma today said it has obtained a favourable ruling from a US Court that paves way for launch of generic Copaxone used for treating multiple sclerosis during May 2014. "The company is pleased to announce the US Court of A...

Andhra Pradesh government lifts 6-year-old ban on bulk-drug plants

Jul 28, 2013 at 12:37 | Source: Economic Times

HYDERABAD: In what comes as a major relief to the pharmaceutical industry, the Andhra Pradesh government has lifted a ban on the expansion of bulk drug manufacturing facilities imposed six years ago to curb pollution. The AP pharma industry, which cu...

Natco clears legal hurdles for launch of Copaxone generic in US

Jul 27, 2013 at 18:07 | Source: The Hindu BusinessLine

Natco Pharma Ltd has been awarded a favourable judgement in the US Court of Appeals for the Federal Circuit ruling on a patent related to Teva’s Copaxone. The court of appeals had reversed a district court’s finding related to the Copaxo...

Sensex ends 114 pts down; Jindal Steel, ONGC, Maruti losers

Jul 02, 2013 at 22:52 | Source: DomainB

4:00 pm Market closing: It was a weak session on Dalal Street. The Sensex ended 113.57 points down at 19463.82, and the Nifty closed at 5857.55, down 41.30 points. 3:40 pm Losers: Jindal Steel , ONGC , Maruti Suzuki, Infosys and Tata Power are loser...

Khoj-Tate in landmark collaboration

Jun 26, 2013 at 11:06 | Source: DNA India

Khoj, the New Delhi-based experimental art studio, is going places. Come July 12 and the Tate Modern in London, Britain s and perhaps the world s foremost art gallery, will open a group exhibition that has been conceptualised as a curatorial collabo...

Uttarakhand: 4 more bodies recovered from chopper crash site, toll reaches 12

Jun 26, 2013 at 11:06 | Source: DNA India

Four more bodies were recovered by IAF commandos near Gaurikund in Uttarakhand where an IAF Mi-17 helicopter carrying 20 people had crashed during a rescue mission and all onboard are feared killed. During night-long search operations, Garud command...

Rupee down 12 paise against dollar in early trade

Jun 26, 2013 at 11:00 | Source: DNA India

The rupee today fell by 12 paise to 59.78 against the dollar in early trade on the Interbank Foreign Exchange market on increased demand for the US currency from importers. A firm opening in the domestic equity market and easing dollar against other...

Indian rupee down 12 paise Vs dollar in early trade

Jun 26, 2013 at 10:46 | Source: Business Today

Increased demand for the US currency from importers led the Indian rupee fall by 12 paise to 59.78 against the dollar in early trade on Wednesday on the Interbank Foreign Exchange market.Forex dealers said a firm opening in the domestic equity marke...

Sensex shrugs off RBI policy; rallies 148 ahead of Fed meet

Jun 17, 2013 at 23:27 | Source: DomainB

Equity benchmarks gained momentum in late trade Monday ahead Federal Reserve's meeting, ignoring RBI's status quo credit policy . BSE Sensex rose 147.94 points or 0.77 percent to close at 19325.87, and NSE Nifty gained 43.10 points or 0.74 percent a...

India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw

Jun 10, 2013 at 15:56 | Source: Economic Times

NEW DELHI: India needs to show the world that it respects intellectual property rights if it wants global pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran Mazumdar-Shaw. She also said India should be ...

How Big Pharma-designed cacophony against Ranbaxy drowns vital voices

Jun 10, 2013 at 15:54 | Source: FirstPost

In the unresisted and rapidly rising cacophony against the FDA-tainted Ranbaxy, what get drowned unfortunately are voices that are vital to the country's drug industry and people's health.Ranbaxy in the eyes of FDA (Food and Drug Administration) is c...

Pharmaceutical exports slow down due to approval delays and recalls

Jun 06, 2013 at 06:00 | Source: Economic Times

HYDERABAD: India's pharmaceutical exports grew at less than half the pace it did last year, hurt by delays in drug approvals and products recalls in some of its key markets. In dollar terms, pharmaceutical exports rose 9.9% in fiscal 2013, compared ...

Tax charge pulls Natco Pharma net down by 19%

May 30, 2013 at 23:07 | Source: The Hindu BusinessLine

Hyderabad, May 30: Natco Pharma Ltd’s standalone net profit decreased 19.3 per cent at Rs 11.72 crore in the fourth quarter ended March 31, 2013 compared to Rs 14.53 crore in the same period last year. The revenue of the Hyderabad-based compan...

Sensex ends up ahead of Q4 GDP data; Tata Motors, M&M lead

May 30, 2013 at 20:12 | Source: DomainB

Equity benchmarks finished higher Thursday after trading in a narrow range for most part of the day. Dealers attributed the late spike to squaring of short positions in the derivatives segment, today being the settlement day for May series. The BSE ...

Dr Reddy’s says ‘have factored in the impact’

May 18, 2013 at 00:17 | Source: The Hindu BusinessLine

Hyderabad, May 17: Pharma major Dr Reddy’s Laboratories Ltd said the new pricing policy might impact 3-4 per cent of its finished dosage sales in the domestic market. The Department of Pharmaceuticals had notified the Drug Prices Control Order...

video of the day

Time to start buying shares, but be patient for 2 years:HSBC AMC

Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.